Positive News SentimentPositive NewsNASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free COCH Stock Alerts $2.69 -0.07 (-2.54%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$2.56▼$2.9250-Day Range$2.76▼$6.8552-Week Range$0.75▼$11.72Volume48,585 shsAverage Volume288,714 shsMarket Capitalization$52.72 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Envoy Medical alerts: Email Address Envoy Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside123.0% Upside$6.00 Price TargetShort InterestHealthy0.54% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.89Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.80) to ($0.78) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.14 out of 5 starsMedical Sector450th out of 931 stocksSurgical Appliances & Supplies Industry12th out of 18 stocks 3.5 Analyst's Opinion Consensus RatingEnvoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEnvoy Medical has only been the subject of 1 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.54% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Envoy Medical has recently increased by 55.56%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for COCH. Previous Next 3.8 News and Social Media Coverage News SentimentEnvoy Medical has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.91 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Envoy Medical this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for COCH on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat Follows2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.67% of the stock of Envoy Medical is held by insiders.Percentage Held by InstitutionsOnly 8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Envoy Medical are expected to grow in the coming year, from ($0.80) to ($0.78) per share.Read more about Envoy Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… About Envoy Medical Stock (NASDAQ:COCH)Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Read More COCH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart COCH Stock News HeadlinesMay 19, 2024 | seekingalpha.comEnvoy Medical Is Pursuing Filling A Hearing Industry VoidMay 16, 2024 | investorplace.comCOCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024May 15, 2024 | finance.yahoo.comEnvoy Medical Reports First Quarter 2024 ResultsMay 15, 2024 | globenewswire.comEnvoy Medical Reports First Quarter 2024 ResultsApril 24, 2024 | finance.yahoo.comEnvoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024April 21, 2024 | finance.yahoo.comEnvoy Medical, Inc. (COCH)April 20, 2024 | prnewswire.comROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 17, 2024 | msn.comEnvoy Medical (COCH) Price Target Increased by 25.00% to 5.10April 17, 2024 | markets.businessinsider.comROSEN, LEADING TRIAL ATTORNEYS, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 15, 2024 | prnewswire.comCOCH LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 5, 2024 | markets.businessinsider.comROSEN, A LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 3, 2024 | prnewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 3, 2024 | finance.yahoo.comEnvoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024April 3, 2024 | globenewswire.comEnvoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024April 3, 2024 | markets.businessinsider.comCOCH Stock Earnings: Envoy Medical Beats EPS, Beats Revenue for Q4 2023April 2, 2024 | globenewswire.comEnvoy Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 29, 2024 | stockhouse.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 26, 2024 | markets.businessinsider.comROSEN, LEADING INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 24, 2024 | prnewswire.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 20, 2024 | markets.businessinsider.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 17, 2024 | prnewswire.comCOCH INVESTOR ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 12, 2024 | globenewswire.comEnvoy Medical to Participate in the 36th Annual ROTH ConferenceMarch 10, 2024 | markets.businessinsider.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 9, 2024 | prnewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 7, 2024 | markets.businessinsider.comROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHSee More Headlines Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today5/28/2024Next Earnings (Estimated)8/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:COCH CUSIPN/A CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+117.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,910,000.00 Net MarginsN/A Pretax Margin-7,718.85% Return on EquityN/A Return on Assets-112.11% Debt Debt-to-Equity RatioN/A Current Ratio1.10 Quick Ratio0.90 Sales & Book Value Annual Sales$320,000.00 Price / Sales169.05 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-30.67Miscellaneous Outstanding Shares19,600,000Free Float19,469,000Market Cap$54.10 million OptionableNot Optionable Beta2.59 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Brent T. Lucas Esq. (Age 41)CEO & Director Comp: $303.66kMr. David R. Wells (Age 62)Chief Financial Officer Comp: $283.77kKey CompetitorsInogenNASDAQ:INGNLakeland IndustriesNASDAQ:LAKECollPlant BiotechnologiesNASDAQ:CLGNAlpha Pro TechNYSE:APTMilestone ScientificNYSE:MLSSView All CompetitorsInsiders & InstitutionsVirtu Financial LLCBought 14,045 shares on 5/20/2024Ownership: 0.072%WealthTrust Asset Management LLCBought 11,316 shares on 5/3/2024Ownership: 0.058%Brent T LucasBought 12,380 shares on 11/21/2023Total: $12,008.60 ($0.97/share)View All Insider TransactionsView All Institutional Transactions COCH Stock Analysis - Frequently Asked Questions Should I buy or sell Envoy Medical stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Envoy Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" COCH shares. View COCH analyst ratings or view top-rated stocks. What is Envoy Medical's stock price target for 2024? 2 equities research analysts have issued 1 year target prices for Envoy Medical's stock. Their COCH share price targets range from $6.00 to $6.00. On average, they predict the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 123.0% from the stock's current price. View analysts price targets for COCH or view top-rated stocks among Wall Street analysts. How have COCH shares performed in 2024? Envoy Medical's stock was trading at $1.8106 at the beginning of the year. Since then, COCH stock has increased by 48.6% and is now trading at $2.69. View the best growth stocks for 2024 here. Are investors shorting Envoy Medical? Envoy Medical saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 35,000 shares, an increase of 55.6% from the April 30th total of 22,500 shares. Based on an average daily volume of 435,200 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.5% of the shares of the company are sold short. View Envoy Medical's Short Interest. When is Envoy Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 21st 2024. View our COCH earnings forecast. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) announced its earnings results on Wednesday, May, 15th. The company reported ($0.32) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by $0.13. The company earned $0.06 million during the quarter, compared to the consensus estimate of $0.08 million. Who are Envoy Medical's major shareholders? Envoy Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.07%) and WealthTrust Asset Management LLC (0.06%). View institutional ownership trends. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:COCH) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesPresident Biden just made a shocking moveStansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
